Roche cancer drug suffers patent setback in India

ZURICH (Reuters) - India has partly revoked patents granted to a Roche Holding AG breast cancer medicine, the Swiss firm said on Sunday, in the latest regulatory setback for western drugmakers trying to crack the fast-growing market.

via Reuters: Health News Read More Here..